Modulating Anti-MicroRNA-21 Activity and Specificity Using Oligonucleotide Derivatives and Length Optimization.

MLA

Muñoz-Alarcón, Andrés, et al. “Modulating Anti-MicroRNA-21 Activity and Specificity Using Oligonucleotide Derivatives and Length Optimization.” ISRN Pharmaceutics, vol. 2012, 2012, p. 407154. EBSCOhost, https://doi.org/10.5402/2012/407154.

APA

Muñoz-Alarcón, A., Guterstam, P., Romero, C., Behlke, M. A., Lennox, K. A., Wengel, J., El Andaloussi, S., & Langel, U. (2012). Modulating Anti-MicroRNA-21 Activity and Specificity Using Oligonucleotide Derivatives and Length Optimization. ISRN Pharmaceutics, 2012, 407154. https://doi.org/10.5402/2012/407154

Chicago

Muñoz-Alarcón, Andrés, Peter Guterstam, Cristian Romero, Mark A Behlke, Kim A Lennox, Jesper Wengel, Samir El Andaloussi, and Ulo Langel. 2012. “Modulating Anti-MicroRNA-21 Activity and Specificity Using Oligonucleotide Derivatives and Length Optimization.” ISRN Pharmaceutics 2012: 407154. doi:10.5402/2012/407154.